Home/Filings/4/0001437749-12-011496
4//SEC Filing

Cashman Christopher M 4

Accession 0001437749-12-011496

CIK 0001417663other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 9:08 AM ET

Size

12.8 KB

Accession

0001437749-12-011496

Insider Transaction Report

Form 4
Period: 2012-11-06
Cashman Christopher M
President and CEO
Transactions
  • Award

    Options

    2012-11-06+600,000600,000 total
    Exercise: $0.21From: 2012-11-06Exp: 2022-11-06Common Stock, $0.001 par value (600,000 underlying)
  • Award

    Options

    2012-11-06+400,000400,000 total
    Exercise: $0.21Exp: 2022-11-06Common Stock, $0.001 par value (400,000 underlying)
  • Award

    Options

    2012-11-06+12,50012,500 total
    Exercise: $0.21From: 2012-11-06Exp: 2022-11-06Common Stock, $0.001 par value (12,500 underlying)
  • Award

    Options

    2012-11-06+37,50037,500 total
    Exercise: $0.21Exp: 2022-11-06Common Stock, $0.001 par value (37,500 underlying)
Holdings
  • Common Stock, $.001 par value

    429,257
Footnotes (2)
  • [F1]The 400,000 options shall vest and become exercisable in increments of 100,000 upon each of the following four events (the "Events"): (i) the first (1st) enrollee in the Company's clinical trial plan, (ii) the twentieth (20th) enrollee, (iii) the fiftieth (50th) enrollee, and (iv) receipt of an FDA approval letter of the dermaPACE device allowance for commercial use; provided, that if the FDA approval letter at subpart (iv) is received prior to the achievement of the enrollment thresholds at subparts (i), (ii), and/or (iii), all options granted under this section but not previously vested shall become vested and immediately exercisable upon receipt of such letter. Any of the Events which have not occurred as of December 31, 2016 shall be considered to have occurred as of December 31, 2016, and all options granted under this section but not previously vested shall become vested and immediately exercisable on such date.
  • [F2]The 37,500 options shall vest and be exercisable based on the following schedule subject to the conditions of the advisory service agreement: (i) 12,500 on February 6, 2013; (ii) 12,500 on May 6, 2013; and, (iii) 12,500 on August 6, 2013.

Issuer

SANUWAVE Health, Inc.

CIK 0001417663

Entity typeother

Related Parties

1
  • filerCIK 0001339269

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 9:08 AM ET
Size
12.8 KB